Skip to content
OpenCapital
Get started

AN2 Therapeutics, Inc. ANTX Q4 2024 Annual earnings

Reported March 25, 2025 · Before market open

EPS-$0.25In line
EPS estimate-$0.25

Next report

Aug 11, 2026 (In 1 week)
EPS estimate-$0.23

Versus estimates

Diluted EPS

Q1 2026-$0.29Miss by $0.06Q4 2025-$0.29Miss by $0.05Q3 2025-$0.31Miss by $0.08Q2 2025-$0.21Beat by $0.10Q1 2025-$0.35Miss by $0.09
Q4 2024-$0.25In line

Ask the moment AN2 Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did AN2 Therapeutics, Inc. report Q4 2024 earnings?
AN2 Therapeutics, Inc. (ANTX) reported Q4 2024 earnings on March 25, 2025 before market open.
What were AN2 Therapeutics, Inc.'s Q4 2024 revenue and EPS?
AN2 Therapeutics, Inc. reported eps of $-0.25 for Q4 2024.
Did AN2 Therapeutics, Inc. beat estimates in Q4 2024?
EPS beat the consensus estimate of $-0.25 by $0.00.
Where can I find AN2 Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-044366) directly on SEC EDGAR. The filing index links above go to sec.gov.